These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 10884051
1. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. Papassotiropoulos A, Lütjohann D, Bagli M, Locatelli S, Jessen F, Rao ML, Maier W, Björkhem I, von Bergmann K, Heun R. Neuroreport; 2000 Jun 26; 11(9):1959-62. PubMed ID: 10884051 [Abstract] [Full Text] [Related]
2. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. Papassotiropoulos A, Lütjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R, Ptok U, Björkhem I, von Bergmann K, Heun R. J Psychiatr Res; 2002 Jun 26; 36(1):27-32. PubMed ID: 11755458 [Abstract] [Full Text] [Related]
3. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. Lütjohann D, Papassotiropoulos A, Björkhem I, Locatelli S, Bagli M, Oehring RD, Schlegel U, Jessen F, Rao ML, von Bergmann K, Heun R. J Lipid Res; 2000 Feb 26; 41(2):195-8. PubMed ID: 10681402 [Abstract] [Full Text] [Related]
4. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins. Vega GL, Weiner M, Kölsch H, von Bergmann K, Heun R, Lutjohan D, Nguyen A, Moore C. Curr Alzheimer Res; 2004 Feb 26; 1(1):71-7. PubMed ID: 15975088 [Abstract] [Full Text] [Related]
5. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. Solomon A, Leoni V, Kivipelto M, Besga A, Oksengård AR, Julin P, Svensson L, Wahlund LO, Andreasen N, Winblad B, Soininen H, Björkhem I. Neurosci Lett; 2009 Oct 02; 462(1):89-93. PubMed ID: 19560513 [Abstract] [Full Text] [Related]
6. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism. Lütjohann D, von Bergmann K. Pharmacopsychiatry; 2003 Sep 02; 36 Suppl 2():S102-6. PubMed ID: 14574622 [Abstract] [Full Text] [Related]
7. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls. Schönknecht P, Lütjohann D, Pantel J, Bardenheuer H, Hartmann T, von Bergmann K, Beyreuther K, Schröder J. Neurosci Lett; 2002 May 10; 324(1):83-5. PubMed ID: 11983301 [Abstract] [Full Text] [Related]
8. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Vega GL, Weiner MF, Lipton AM, Von Bergmann K, Lutjohann D, Moore C, Svetlik D. Arch Neurol; 2003 Apr 10; 60(4):510-5. PubMed ID: 12707064 [Abstract] [Full Text] [Related]
9. Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms. Vega GL, Weiner MF. J Mol Neurosci; 2007 Sep 10; 33(1):51-5. PubMed ID: 17901546 [Abstract] [Full Text] [Related]
10. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study. Zuliani G, Donnorso MP, Bosi C, Passaro A, Dalla Nora E, Zurlo A, Bonetti F, Mozzi AF, Cortese C. BMC Neurol; 2011 Oct 04; 11():121. PubMed ID: 21970714 [Abstract] [Full Text] [Related]
11. Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. Kölsch H, Heun R, Kerksiek A, Bergmann KV, Maier W, Lütjohann D. Neurosci Lett; 2004 Sep 30; 368(3):303-8. PubMed ID: 15364416 [Abstract] [Full Text] [Related]
12. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. Locatelli S, Lütjohann D, Schmidt HH, Otto C, Beisiegel U, von Bergmann K. Arch Neurol; 2002 Feb 30; 59(2):213-6. PubMed ID: 11843691 [Abstract] [Full Text] [Related]
13. The role of 24S-hydroxycholesterol in Alzheimer's disease. Kölsch H, Lütjohann D, von Bergmann K, Heun R. J Nutr Health Aging; 2003 Feb 30; 7(1):37-41. PubMed ID: 12679839 [Abstract] [Full Text] [Related]
14. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Kölsch H, Lütjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R. Mol Psychiatry; 2002 Feb 30; 7(8):899-902. PubMed ID: 12232784 [Abstract] [Full Text] [Related]
15. Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients. Sauder S, Kölsch H, Lütjohann D, Schulz A, von Bergmann K, Maier W, Heun R. J Neural Transm (Vienna); 2005 Oct 30; 112(10):1381-9. PubMed ID: 15666037 [Abstract] [Full Text] [Related]
16. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels. Fourgeux C, Martine L, Björkhem I, Diczfalusy U, Joffre C, Acar N, Creuzot-Garcher C, Bron A, Bretillon L. Invest Ophthalmol Vis Sci; 2009 Dec 30; 50(12):5712-7. PubMed ID: 19553612 [Abstract] [Full Text] [Related]
17. CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer's Disease. Li L, Zeng F, Liu YH, Li HY, Dong SY, Peng ZY, Wang YJ, Zhou HD. Mol Neurobiol; 2018 Oct 30; 55(10):8179-8187. PubMed ID: 29516283 [Abstract] [Full Text] [Related]
18. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Bretillon L, Sidén A, Wahlund LO, Lütjohann D, Minthon L, Crisby M, Hillert J, Groth CG, Diczfalusy U, Björkhem I. Neurosci Lett; 2000 Oct 27; 293(2):87-90. PubMed ID: 11027840 [Abstract] [Full Text] [Related]